Proactive Investors - Run By Investors For Investors

Ocutrx Vision Technologies looks to treat blindness with augmented reality device

Ocutrx Vision Technologies Chief Scientific and Strategy Officer Dr. Linda Lam tells Proactive Investors the Irvine, California-based technology company aims to treat macular degeneration, or blindness, with its augmented reality device called Oculenz ARwear Glasses.

The privately held company plans to commercialize Oculenz in 2020

View full Octrx profile View Profile

Ocutrx Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use